Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review.
about
Induced pluripotent stem cells as a disease modeling and drug screening platformClinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem CellsA novel 3D label-free monitoring system of hES-derived cardiomyocyte clusters: a step forward to in vitro cardiotoxicity testingNon-Invasive Acoustical sensing of Drug-Induced Effects on the Contractile Machinery of Human Cardiomyocyte Clusters.Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays.Stem cell bioprocess engineering towards cGMP production and clinical applicationsEngineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.Tissue-Engineering for the Study of Cardiac Biomechanics.Cardiac differentiation of human pluripotent stem cellsElectrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells.Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytesCardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models.The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening.Prospective in vitro models of channelopathies and cardiomyopathiesConcise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes.Cardiomyocyte culture - an update on the in vitro cardiovascular model and future challenges.Cardiotoxicity screening: a review of rapid-throughput in vitro approaches.Cryopreservation of Human Pluripotent Stem Cell-Derived Cardiomyocytes: Strategies, Challenges, and Future Directions.Micropatterned co-culture of cardiac myocytes on fibrous scaffolds for predictive screening of drug cardiotoxicities.High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model.Global transcriptional profiling reveals similarities and differences between human stem cell-derived cardiomyocyte clusters and heart tissue.Stem cell derived in vivo-like human cardiac bodies in a microfluidic device for toxicity testing by beating frequency imaging.Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment.Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells.Alterations of field potentials in isotropic cardiomyocyte cell layers induced by multiple endogenous pacemakers under normal and hypothermal conditions.Macroporous microcarriers for introducing cells into a microfluidic chip.Reducing the toxicity of cancer therapy: recognizing needs, taking action.Human-Induced Pluripotent Stem Cell Technology and Cardiomyocyte Generation: Progress and Clinical Applications.
P2860
Q26865689-E6EA43CA-F3F4-4021-86AE-4EC8ABBE68FBQ27021919-4327622B-0558-4BD2-87CC-0ED8D27E2D5AQ27311346-11E5AC9D-B067-4421-A9AB-71E2C21CFDCCQ28547148-632CC6A1-BED9-4508-A1EE-CA5E5374124CQ30558954-FC1F3924-04E0-4114-BAB9-E9A1658C19B5Q34150828-16FA4E34-37BB-4DAE-87DC-6A4CA5F44EE9Q36421944-37A1994F-F186-41CA-9AC4-7E12B130D15CQ36836302-2AF2B5E8-9EA2-4BD9-A7B6-8214853CC0B2Q37294215-1A62C85D-C7E1-4AA9-BCEF-7FA053B0E4D4Q37542604-413F5E3E-28AC-4511-8990-25DB39FAC131Q37692479-2AE4FE45-A415-4DBC-9A27-12C96ED0E0BEQ37959029-028EE1E9-F1AC-40E7-9D65-ADBD605639FDQ38030589-8D2CE250-0F52-4C19-812F-CDE2D956CD1DQ38042625-5E6DFF3B-01BB-4E26-AE51-94A59B84C44CQ38077159-10973FBF-838A-4660-8154-8879265473C4Q38167330-A1908942-1C3E-4539-945A-1DE85DB37792Q38671689-D99631B1-2AE5-4CE9-835D-28159FF8C6F7Q38796118-A3D8C1CC-10AC-4EBC-AE5C-6C672C2578E5Q38851260-06665C53-E7CE-40EC-AD4C-AE85A2F3E0B8Q39253982-99B78A29-6F09-4793-9D31-7639C279BBD0Q39676022-E772EF82-69E0-4A44-A13C-C5569BDAB2CDQ40775564-A00F91CC-E2E9-43A1-ADE1-2B191023B77CQ42197966-B14EDA6E-F4A8-461D-BE59-4F458012A711Q47611653-FAF0271A-BFD8-4DAC-AB01-9D994114C8B9Q51062305-B106AF1B-62F3-4BD1-9F3C-136C03F83641Q51511584-A2720E6C-0891-46E6-9324-0E9EBA504034Q51581622-DC45991A-D72D-4710-873C-0F49D4ED74D5Q55499094-7F8E99AF-E1C1-4573-B5FF-95D61F57BBDD
P2860
Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiotoxicity testing using p ...... he-art bioanalytics: a review.
@en
Cardiotoxicity testing using p ...... he-art bioanalytics: a review.
@nl
type
label
Cardiotoxicity testing using p ...... he-art bioanalytics: a review.
@en
Cardiotoxicity testing using p ...... he-art bioanalytics: a review.
@nl
prefLabel
Cardiotoxicity testing using p ...... he-art bioanalytics: a review.
@en
Cardiotoxicity testing using p ...... he-art bioanalytics: a review.
@nl
P2093
P2860
P356
P1476
Cardiotoxicity testing using p ...... the-art bioanalytics: a review
@en
P2093
Carl-Fredrik Mandenius
Daniella Steel
Elmar Heinzle
Peter Sartipy
Reiner Class
Sarina Arain
Susanne Bremer
Thomas Meyer
Udo Kraushaar
P2860
P304
P356
10.1002/JAT.1663
P407
P50
P577
2011-02-16T00:00:00Z